• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Comparison of DNA sequences on VZV glycoproteins of the Oka vaccine and parental Oka strains

Research Project

Project/Area Number 12670795
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatrics
Research InstitutionKAWASAKI MEDICAL SCHOOL

Principal Investigator

TERADA Kihei  Kawasaki Medical School,Medicine, Assistant Professor, 医学部, 講師 (50172094)

Co-Investigator(Kenkyū-buntansha) INOUE Miwa  Kawasaki Medical School, Faculty Assistant, 医学部, 助手 (90330555)
OGITA Satoko  Kawasaki Medical School, Faculty Assistant, 医学部, 助手 (40309555)
Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥3,400,000 (Direct Cost: ¥3,400,000)
Fiscal Year 2001: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2000: ¥2,200,000 (Direct Cost: ¥2,200,000)
Keywordsvaricella vaccine / varicella zoster virus / glycoprotein / シークエンス / 水痘帯状疱疹ウイルス
Research Abstract

The Oka vaccine strain, derived from a Japanese clinical isolate (parental Oka strain) through tissue cultures, induces the immunity without the clinical manifestations. We do not know the molecular characteristics of the viral virulence. VZV genome encodes at least six glycoproteins, which are expressed in the outer membrane of an infected cell. The glycoproteins induce cellular and humoral immunity in the host with the infection. To investigate the virologic basis for the clinical attenuation of the Oka vaccine strain, we compared gE, gl and gC of the Oka vaccine strain with that of the parental strain by DNA sequence analysis. VZV gE is thought to be essential but not VZV gl and gC for viral replication. The DNA sequence of gE and gl in the Oka vaccine strain was completely consistent with that in the parental Oka strain, respectively. Thus the Oka vaccine strain can induce the same immunity as the wild virus does. However, the sequence of gC in the Oka vaccine strain was different from that of the parental strain in point mutations and the number of repeats.

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] Niizuma T, Terada K, Kataoka N, Nishimatsu S, Nohno T: "Comparison of the DNA sequence on VZV glycoproteins of the Oka vaccine strain and the parental strain"Internat Pediatr. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Terada K, Yagi Y, Niizuma T.Kataoka N: "Is oral tolerance therapy for hemophilia with inhibitors possible?"Vox Sag. 80. 61-62 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] NiizumaT et ah.: "Comparison of me DNA sequence on VZV glycoproteins of the Oka vaccine strain arid the parental strain."Internal Pediatr. (in press). 61-62

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] TeradaKetal.: "Is oral tolerance therapy for hemophilia with inhibitors possible?"J Immunel. 80. 1698-1702 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] ArigaTet al.: "Molecular basis for paradoxical carriers of adenosine deaminase (ADA) deficiency that show extremely low lev-els of ADA activity in peripheral blood cells without immunodeficiency."Blood. 166. 2896-2899 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] ArigaTet al.: "T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed therestoration of ADA activity resulted from the reversion of an inherited mutation."J Med Virol. 97. 46-51 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Terada K et al.: "Low induction of varicella-zoster virus (VZV)specific secretory IgA antibody after vaccination."Pediatr Infect Dis J. 62. 104-108 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Terada K et al: "Testing for rubella specific IgG antibody in urine."19. (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Niizuma T, Terada K, Kataoka N, Nishimatsu S, Nohno T: "Comparison of the DNA sequence on VZV glycoproteins of the Oka vaccine strain and the parental strain"Internat Pediatr. (in press).

    • Related Report
      2001 Annual Research Report
  • [Publications] Terada K, Yagi Y, Niizuma T, Kataoka N: "Is oral tolerance therapy for hemophilia with inhibitors possible?"Vox Sag. 80. 61-62 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Terada K, et al: "Testing for rubella specific IgG in urine."Pediatr Infect Dis J. 19. 104-108 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Terada K, et al: "Low induction of varicella-zoster virus specific secretory IgA antibody after vaccination."J Med Virol. 62. 46-51 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Terada K, et al: "Is oral tolerance therapy for hemophilia with inhibitors possible?"Vox Sag. (in press).

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi